Laurion Capital Management’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-824,380
| Closed | -$31.7M | – | 474 |
|
|
2023
Q2 | $31.7M | Sell |
824,380
-5,370
| -0.6% | -$206K | 0.18% | 20 |
|
|
2023
Q1 | $19.2M | Hold |
829,750
| – | – | 0.13% | 28 |
|
|
2022
Q4 | $21.7M | Buy |
829,750
+643
| +0.1% | +$16.8K | 0.1% | 27 |
|
|
2022
Q3 | $16.3M | Sell |
829,107
-643
| -0.1% | -$12.6K | 0.1% | 48 |
|
|
2022
Q2 | $14.5M | Buy |
829,750
+75,000
| +10% | +$1.31M | 0.22% | 30 |
|
|
2022
Q1 | $12.3M | Buy |
754,750
+200,500
| +36% | +$3.28M | 0.15% | 36 |
|
|
2021
Q4 | $9.04M | Buy |
+554,250
| New | +$9.04M | 0.09% | 65 |
|
|
2016
Q2 | – | Sell |
-4,880
| Closed | -$313K | – | 791 |
|
|
2016
Q1 | $313K | Buy |
+4,880
| New | +$313K | ﹤0.01% | 313 |
|